Prestige Biologics

334970 · KOSDAQ · ₩334970 · 프레스티지바이오로직스

₩1,158▼ ₩35 (2.93%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩13B₩2.2B₩1.7B₩16M₩3.2B
Cost of sales₩28B₩11B₩1.2B₩12M₩873M
Gross profit−₩16B−₩8.7B₩518M₩3.6M₩2.4B
Operating income−₩34B−₩33B−₩22B−₩37B−₩27B
Net income−₩27B−₩29B−₩18B−₩50B−₩39B
Net income to shareholders−₩27B−₩29B−₩18B−₩50B−₩39B

Balance sheet

20252024202320222021
Total assets₩270B₩289B₩306B₩258B₩207B
Current assets₩41B₩56B₩70B₩30B₩55B
Cash and equivalents₩1.6B₩30B₩45B₩15B₩37B
Total liabilities₩135B₩218B₩206B₩140B₩100B
Current liabilities₩102B₩92B₩89B₩33B₩28B
Borrowings₩91B₩173B₩160B₩119B₩78B
Total equity₩135B₩72B₩100B₩118B₩107B
Shareholders' equity₩135B₩72B₩100B₩118B₩107B

Cash flow

20252024202320222021
Cash from operations−₩18B−₩8.3B−₩4.4B−₩34B−₩26B
Capital spending₩5.2B₩8.5B₩19B₩85B—
Free cash flow−₩24B−₩17B−₩24B−₩119B−₩26B

Consolidated where available. Amounts in won.

Also known as: Prestige Biologics / 프레스티지바이오로직스 / 334970 / KRX:334970

Source: KRX statistical information